CeQur of Horw, Switzerland received European approval for the PaQ Insulin Delivery Device. The PaQ provides three days of continuous insulin infusion for patients with type 2 diabetes, and also offers the option for users to initiate an extra bolus injection at any time.
The device consists of a disposable insulin container that connects to a reusable electronic component that can provide on-demand information on the status of the PaQ.
From the company announcement:
The CeQur insulin infuser includes a disposable insulin reservoir that attaches to a reusable electronic messenger. The device easily attaches to the patient’s abdominal area with a safe and secure adhesive backing. Once in place, insulin is delivered subcutaneously through a fine, soft tube or cannula from the reservoir that is changed by the patient every few days.
The CeQur insulin delivery device is designed to use just one type of insulin for both basal and bolus dosing, and will be available in multiple basal rates.
Press release: CeQur Receives CE Mark for PaQ® Insulin Delivery Device
Product page: CeQur PaQ…
